CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 21 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $434,003 | -28.0% | 535,005 | 0.0% | 0.07% | -14.5% |
| Q2 2023 | $602,640 | -18.5% | 535,005 | -27.7% | 0.08% | -12.6% |
| Q1 2023 | $739,575 | +15.2% | 739,649 | 0.0% | 0.10% | -3.1% |
| Q4 2022 | $641,867 | -32.7% | 739,649 | 0.0% | 0.10% | -51.2% |
| Q3 2022 | $954,000 | +48.4% | 739,649 | 0.0% | 0.20% | +22.6% |
| Q2 2022 | $643,000 | -6.5% | 739,649 | +224.8% | 0.16% | -26.5% |
| Q1 2022 | $688,000 | – | 227,759 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $36,004,000 | 0.64% |
| Octagon Capital Advisors LP | 279,921 | $1,442,000 | 0.28% |
| Altium Capital Management LP | 175,000 | $901,000 | 0.25% |
| Deep Track Capital, LP | 647,057 | $3,332,000 | 0.24% |
| Ikarian Capital, LLC | 262,237 | $1,350,000 | 0.20% |
| Cormorant Asset Management, LP | 200,000 | $1,030,000 | 0.06% |
| DLD Asset Management, LP | 121,707 | $627,000 | 0.03% |
| RTW INVESTMENTS, LP | 450,000 | $2,318,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,250,000 | $6,438,000 | 0.01% |
| Chicago Partners Investment Group LLC | 21,892 | $97,000 | 0.01% |